What is thrombocytosis, and what does a low-risk CALR mutation mean for someone recently diagnosed?
Thrombocytosis means having too many platelets in your blood. In myeloproliferative neoplasms, this happens when your bone marrow produces an excess of platelets, which are the blood cells responsible for clotting.
When you Show Full Answer
What is thrombocytosis, and what does a low-risk CALR mutation mean for someone recently diagnosed?
Thrombocytosis means having too many platelets in your blood. In myeloproliferative neoplasms, this happens when your bone marrow produces an excess of platelets, which are the blood cells responsible for clotting.
When you have too many platelets, it can lead to abnormal blood clotting and blockages in blood vessels. In some cases, it can also cause excessive bleeding.
The CALR mutation is one of three common genetic changes found in MPNs. CALR stands for calreticulin, a gene that helps control calcium levels in cells. When this gene mutates, it can contribute to the overproduction of blood cells.
Having a CALR mutation is actually associated with some positive features:
* Research suggests people with CALR mutations may have less severe symptoms
* The disease often progresses more slowly compared to other mutations
* It's commonly found in essential thrombocythemia and primary myelofibrosis
Your doctor identified this mutation through genetic testing, which helps them recommend the most effective treatment options for your specific situation. The "low-risk" designation is encouraging and suggests a more favorable outlook.
January 1
Join
Your Privacy Choices
